GB201103582D0 - - Google Patents

Info

Publication number
GB201103582D0
GB201103582D0 GBGB1103582.1A GB201103582A GB201103582D0 GB 201103582 D0 GB201103582 D0 GB 201103582D0 GB 201103582 A GB201103582 A GB 201103582A GB 201103582 D0 GB201103582 D0 GB 201103582D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1103582.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nucana PLC
Original Assignee
Nucana Biomed Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nucana Biomed Ltd filed Critical Nucana Biomed Ltd
Priority to GBGB1103582.1A priority Critical patent/GB201103582D0/en
Publication of GB201103582D0 publication Critical patent/GB201103582D0/en
Priority to EP12709146.0A priority patent/EP2681227B1/en
Priority to PL18178715T priority patent/PL3447061T3/pl
Priority to PL12709146T priority patent/PL2681227T3/pl
Priority to HUE12709146A priority patent/HUE029022T2/en
Priority to LTEP18178715.1T priority patent/LT3447061T/lt
Priority to US14/000,682 priority patent/US8933053B2/en
Priority to KR1020137025749A priority patent/KR101885940B1/ko
Priority to RS20160211A priority patent/RS54776B1/sr
Priority to ES12709146.0T priority patent/ES2569185T3/es
Priority to BR112013021986-6A priority patent/BR112013021986B1/pt
Priority to CN201510329656.2A priority patent/CN104974206B/zh
Priority to PT181787151T priority patent/PT3447061T/pt
Priority to DK18178715.1T priority patent/DK3447061T3/da
Priority to MX2013009815A priority patent/MX339822B/es
Priority to DK16150494.9T priority patent/DK3031812T3/en
Priority to HUE18178715A priority patent/HUE060127T2/hu
Priority to SI201231972T priority patent/SI3447061T1/sl
Priority to EP16150494.9A priority patent/EP3031812B1/en
Priority to RS20211549A priority patent/RS62721B1/sr
Priority to EP21209926.1A priority patent/EP4023299A1/en
Priority to PT16150494T priority patent/PT3031812T/pt
Priority to ES16150494.9T priority patent/ES2686219T3/es
Priority to PCT/GB2012/050457 priority patent/WO2012117246A1/en
Priority to ES18178715T priority patent/ES2903097T3/es
Priority to CA2828326A priority patent/CA2828326C/en
Priority to NZ615270A priority patent/NZ615270A/en
Priority to JP2013555935A priority patent/JP5978232B2/ja
Priority to DK12709146.0T priority patent/DK2681227T3/da
Priority to EP18178715.1A priority patent/EP3447061B1/en
Priority to CN201280010761.4A priority patent/CN103403013B/zh
Priority to PL16150494T priority patent/PL3031812T3/pl
Priority to RU2013143862A priority patent/RU2614406C2/ru
Priority to AU2012223012A priority patent/AU2012223012C1/en
Priority to SI201230488T priority patent/SI2681227T1/sl
Priority to SG2013062823A priority patent/SG192841A1/en
Priority to HRP20211967TT priority patent/HRP20211967T1/hr
Priority to IL228169A priority patent/IL228169A/en
Priority to CL2013002517A priority patent/CL2013002517A1/es
Priority to ZA2013/06468A priority patent/ZA201306468B/en
Priority to HK14105963.6A priority patent/HK1192758A1/zh
Priority to US14/560,097 priority patent/US9221866B2/en
Priority to ZA2014/09013A priority patent/ZA201409013B/en
Priority to PH12015500485A priority patent/PH12015500485B1/en
Priority to US14/943,555 priority patent/US9655915B2/en
Priority to HRP20160346TT priority patent/HRP20160346T1/hr
Priority to CY20161100360T priority patent/CY1117445T1/el
Priority to SM201600132T priority patent/SMT201600132B/it
Priority to US15/489,884 priority patent/US10022390B2/en
Priority to US16/021,103 priority patent/US10993957B2/en
Priority to US17/223,241 priority patent/US11559542B2/en
Priority to CY20211101114T priority patent/CY1124871T1/el
Priority to US18/095,937 priority patent/US11925658B2/en
Ceased legal-status Critical Current

Links

GBGB1103582.1A 2011-03-01 2011-03-01 Ceased GB201103582D0 (sl)

Priority Applications (53)

Application Number Priority Date Filing Date Title
GBGB1103582.1A GB201103582D0 (sl) 2011-03-01 2011-03-01
EP12709146.0A EP2681227B1 (en) 2011-03-01 2012-02-29 Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
PL18178715T PL3447061T3 (pl) 2011-03-01 2012-02-29 Farmaceutyczna formulacja zawierająca pochodną fosforoamidynianową 5-fluoro-2'-deoksyurydyny do zastosowania w leczeniu nowotworu
PL12709146T PL2681227T3 (pl) 2011-03-01 2012-02-29 Amidofosforanowe pochodne 5-fluoro-2'-deoksyurydyny do zastosowania w leczeniu raka
HUE12709146A HUE029022T2 (en) 2011-03-01 2012-02-29 Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
LTEP18178715.1T LT3447061T (lt) 2011-03-01 2012-02-29 Farmacinė vaisto forma, apimanti 5-fluor-2'-deoksiuridinofosforamidato darinį, skirtą naudoti vėžio gydymui
US14/000,682 US8933053B2 (en) 2011-03-01 2012-02-29 Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
KR1020137025749A KR101885940B1 (ko) 2011-03-01 2012-02-29 암 치료에 사용하기 위한 5-플루오로-2'-데옥시우리딘의 포스포르아미데이트 유도체
RS20160211A RS54776B1 (sr) 2011-03-01 2012-02-29 Fosforoamidatni derivati 5-fluoro-2'-dezoksiuridina za upotrebu u tretmanu kancera
ES12709146.0T ES2569185T3 (es) 2011-03-01 2012-02-29 Derivados de fosforamidato de 5-fluoro-2'-desoxiuridina para uso en el tratamiento del cáncer
BR112013021986-6A BR112013021986B1 (pt) 2011-03-01 2012-02-29 Derivados de fosforamidato de 5-fluoro-2'-desoxiuridina, seus usos e seu processo de preparação, composição farmacêutica e seu método de preparação
CN201510329656.2A CN104974206B (zh) 2011-03-01 2012-02-29 用于治疗癌症的5-氟-2’-脱氧尿苷的氨基磷酸酯衍生物
PT181787151T PT3447061T (pt) 2011-03-01 2012-02-29 Formulação farmacêutica que compreende um derivado de fosforamidato de 5-fluoro-2¿-desoxiuridina para utilização no tratamento de cancro
DK18178715.1T DK3447061T3 (da) 2011-03-01 2012-02-29 Farmaceutisk formulering omfattende et phosphoramidatderivat af 5-fluor-2'-deoxyuridin til anvendelse i cancerbehandling
MX2013009815A MX339822B (es) 2011-03-01 2012-02-29 Derivados de fosforoamidato de 5-fluoro-2'-desoxiuridina para uso en el tratamiento contra el cancer.
DK16150494.9T DK3031812T3 (en) 2011-03-01 2012-02-29 CHEMICAL COMPOUNDS
HUE18178715A HUE060127T2 (hu) 2011-03-01 2012-02-29 Az 5-fluor-2'-deoxiuridin foszforamidát-származékot tartalmazó gyógyszerkészítmények a rák kezelésében való felhasználásra
SI201231972T SI3447061T1 (sl) 2011-03-01 2012-02-29 Farmacevtska formulacija, ki obsega fosforamidni derivat 5-fluoro-2'-deoksiuridina za uporabo pri zdravljenju raka
EP16150494.9A EP3031812B1 (en) 2011-03-01 2012-02-29 Chemical compounds
RS20211549A RS62721B1 (sr) 2011-03-01 2012-02-29 Farmaceutska formulacija koja sadrži fosforamidatni derivat 5-fluoro-2’-deoksiuridina za upotrebu u lečenju kancera
EP21209926.1A EP4023299A1 (en) 2011-03-01 2012-02-29 Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
PT16150494T PT3031812T (pt) 2011-03-01 2012-02-29 Compostos químicos
ES16150494.9T ES2686219T3 (es) 2011-03-01 2012-02-29 Compuestos químicos
PCT/GB2012/050457 WO2012117246A1 (en) 2011-03-01 2012-02-29 Phosphoramidate derivatives of 5 - fluoro - 2 ' - deoxyuridine for use in the treatment of cancer
ES18178715T ES2903097T3 (es) 2011-03-01 2012-02-29 Formulación farmacéutica que comprende un derivado de fosforamidato de 5-fluoro-2'-desoxiuridina para su uso en el tratamiento del cáncer
CA2828326A CA2828326C (en) 2011-03-01 2012-02-29 Phosphoramidate derivatives of 5 - fluoro - 2' - deoxyuridine for use in the treatment of cancer
NZ615270A NZ615270A (en) 2011-03-01 2012-02-29 Phosphoramidate derivatives of 5 - fluoro - 2 ‘ - deoxyuridine for use in the treatment of cancer
JP2013555935A JP5978232B2 (ja) 2011-03-01 2012-02-29 がん治療での使用のための５−フルオロ−２’−デオキシウリジンのホスホラミダート誘導体
DK12709146.0T DK2681227T3 (da) 2011-03-01 2012-02-29 Phosphoramidatderivater af 5-fluor-2'-deoxyuridin til anvendelse i behandlingen af cancer
EP18178715.1A EP3447061B1 (en) 2011-03-01 2012-02-29 Pharmaceutical formulation comprising a phosphoramidate derivative of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
CN201280010761.4A CN103403013B (zh) 2011-03-01 2012-02-29 用于治疗癌症的5-氟-2’-脱氧尿苷的氨基磷酸酯衍生物
PL16150494T PL3031812T3 (pl) 2011-03-01 2012-02-29 Związki chemiczne
RU2013143862A RU2614406C2 (ru) 2011-03-01 2012-02-29 Фосфороамидатные производные 5-фтор-2'-дезоксиуридина для применения для лечения рака
AU2012223012A AU2012223012C1 (en) 2011-03-01 2012-02-29 Phosphoramidate derivatives of 5 - fluoro - 2 ' - deoxyuridine for use in the treatment of cancer
SI201230488T SI2681227T1 (sl) 2011-03-01 2012-02-29 Fosforamidatni derivati 5-fluoro-2'-deoksiuridina za uporabo pri zdravljenju raka
SG2013062823A SG192841A1 (en) 2011-03-01 2012-02-29 Phosphoramidate derivatives of 5 - fluoro - 2 ' - deoxyuridine for use in the treatment of cancer
HRP20211967TT HRP20211967T1 (hr) 2011-03-01 2012-02-29 Farmaceutska formulacija koja sadrži fosforamidatni derivat 5-fluoro-2'-deoksiuridina za uporabu u liječenju raka
IL228169A IL228169A (en) 2011-03-01 2013-08-28 Use of Phosphoramidate Derivatives of 5-Floro-2-Deoxyuridine for Cancer Treatment
CL2013002517A CL2013002517A1 (es) 2011-03-01 2013-08-30 Compuestos derivados de fosforoamidato de 5-fluoro-2'-desoxiuridina; procedimiento de preparacion; composicion farmaceutica que los comprende; su uso en el tratamiento o profilaxis del cancer.
ZA2013/06468A ZA201306468B (en) 2011-03-01 2013-09-09 Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
HK14105963.6A HK1192758A1 (zh) 2011-03-01 2014-06-23 '- 用於治療癌症的 -氟- '-脱氧尿苷的氨基磷酸酯衍生物
US14/560,097 US9221866B2 (en) 2011-03-01 2014-12-04 Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
ZA2014/09013A ZA201409013B (en) 2011-03-01 2014-12-09 Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
PH12015500485A PH12015500485B1 (en) 2011-03-01 2015-03-05 Phosphoramidate derivatives of 5 - fluoro - 2` - deoxyuridine for use in the treatment of cancer
US14/943,555 US9655915B2 (en) 2011-03-01 2015-11-17 Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
HRP20160346TT HRP20160346T1 (hr) 2011-03-01 2016-04-05 Fosforoamidatni derivati 5-fluoro-2'-deoksiuridina za upotrebu u tretmanu raka
CY20161100360T CY1117445T1 (el) 2011-03-01 2016-04-27 Παραγωγα φωσφοραμιδικου της 5-φθορο-2´-δεοξυουριδινης για χρηση στην θεραπεια καρκινου
SM201600132T SMT201600132B (it) 2011-03-01 2016-05-06 Derivati fosforammidati di 5-fluoro-2'-desossiuridina per uso nel trattamento del cancro
US15/489,884 US10022390B2 (en) 2011-03-01 2017-04-18 Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
US16/021,103 US10993957B2 (en) 2011-03-01 2018-06-28 Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
US17/223,241 US11559542B2 (en) 2011-03-01 2021-04-06 Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
CY20211101114T CY1124871T1 (el) 2011-03-01 2021-12-17 Φαρμακευτικα σκευασματα που περιλαμβανουν παραγωγα φωσφοραμιδιου της 5-φθορο-2'-δεοξυουριδινη προς χρηση στη θεραπεια του καρκινου
US18/095,937 US11925658B2 (en) 2011-03-01 2023-01-11 Phosphoramidate derivatives of 5-fluoro-2′—deoxyuridine for use in the treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1103582.1A GB201103582D0 (sl) 2011-03-01 2011-03-01

Publications (1)

Publication Number Publication Date
GB201103582D0 true GB201103582D0 (sl) 2011-04-13

Family

ID=43904458

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1103582.1A Ceased GB201103582D0 (sl) 2011-03-01 2011-03-01

Country Status (1)

Country Link
GB (1) GB201103582D0 (sl)

Similar Documents

Publication Publication Date Title
BR112013022641A2 (sl)
AP3853A (sl)
BR112013031251A2 (sl)
BR112013027245A2 (sl)
BR112013024383A2 (sl)
BR112013026905A2 (sl)
BR112013023185A2 (sl)
BR112013022995A2 (sl)
BR112013027830A2 (sl)
BR112013017670A2 (sl)
BR112013023927A2 (sl)
BR112013024365A2 (sl)
BR112013028733A2 (sl)
BR112013027121A2 (sl)
BR112013027452A2 (sl)
AP2016009466A0 (sl)
BR112013031556A2 (sl)
BR112013024588A2 (sl)
BR112013026790A2 (sl)
BR112013032377A2 (sl)
BR112013032380A2 (sl)
BR112013032366A2 (sl)
BR112013026895A2 (sl)
BR112013018949A2 (sl)
BR112013027836A2 (sl)

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)